Díaz AFA, Hernández SS, Domínguez BRA, Choque AJ, Gálvez LME

Language: Spanish
References: 11
Page: 101-107
PDF size: 401.71 Kb.

ABSTRACT

Worldwide our contry ranks second highest place for obesity in adults and the first place for pediatric patients. The management of obesity treated with surgery has increased exponentially in the last decade and is now among the most commonly performed.1 In the United States, the procedure of laparoscopic adjustable gastric banding was introduced in 2001 and has been gaining popularity. With the introduction of the laparoscopic approach, the public now see bariatric surgery as a less invasive procedure to treat a chronic disease that can threaten their health and longevity. Along with the laparoscopic revolution, huge efforts were initiated to develop a new standard for safety, with a focus on improving the results. Emerging data support the role of bariatric surgery as an effective treatment for the improvement or remission of type 2 diabetes, hypertension, dyslipidemia, and other concomitant diseases that accompany obesity. The mechanisms involved in remission of these conditions, however, remain poorly understood and constitute an interesting area of research. We report a case of an adult that present morbid obesity with weigh of 120 kg, height 1.60 meters and a body mass index of 46.87, which underwent a gastric bypass surgery and during post-operative, developed several complications in our unit (ICU), which required multiples medical and surgical interventions. The intention to publicize the case is to recognize the potential complications of bariatric surgery and to keep in mind that although it is an innovative procedure, is essential wear out the resource of prevention and medical treatment of obesity, before submitting the patient to the risk of this type of post-surgical complications.

REFERENCES

1. http://www.inegi.gob.mx/est/contenidos/espanol/tematicos/mediano/med.asp?t=mpob45

2. Koch TR, Finelli FC. Postopera metabolic and nutritional complications of bariatric surgery. Clinics of North America 2010;86:109-124.

3. Fontana MA, Wohlgemuth SD. The surgical treatment of metabolic disease and morbid obesity. Clinics of North America 2010;39:125-133.

4. Smith BR, Schauer P, Nguyen NT. Surgical approaches to the treatment of obesity: bariatric surgery. Clinics of North America 2008;37:943-964.

5. Leslie D, Kellogg TA, Ikramuddin S. Bariatric surgery primer for the internist: keys to the surgical consultation. Clinics of North America 2007;91:353-381.

6. Lopez PP, Patel NA, Koche LS. Outpatient complications encountered following Roux-in-Y gastric bypass. Clinics of North America 2007;91:471-483.

7. Escalona A. Complicaciones quirúrgicas en bypass gástrico laparoscópico. Complicaciones quirúrgicas en bypass gástrico. Revista Chilena de Cirugía 2006;2:97-105.

8. Kini S, Herron DM, Yanagisawa RT. Bariatric surgery for morbid obesity a cure for metabolic syndrome? Clinics of North America 2007;91:1255-1271.

9. Powers KA, Rehrig ST, Jones DB. Financial impact of obesity and bariatric surgery. Clinics of North America 2007;91:321-338.

10. Yurcisin BM, Gaddor MM, DeMaria EJ. Obesity and bariatric surgery Department of Surgery, Duke University Medical Center. Clin Chest Med 2009;30:539-553.

11. Carucci LR, Turner MA, Yu J. Imaging evaluation following Roux-in-Y gastric bypass surgery for morbid obesity. Radiol Clinics 2007;45:247-260.